Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hikma Doubles Down On R&D Investment In 2025
The Company Plans To Increase R&D Spend By 20%
Mar 04 2025
•
By
Adam Zamecnik
• Source: Shutterstock
More from Earnings
More from Generics Bulletin